BABA
Alibaba Group Holding Limited
BABA has slightly lower modeled downside risk, despite its lower overall score.
CRWS
Crown Crafts, Inc.
CRWS has the edge over BABA overall, supported by stronger valuation and stronger fundamentals.
BABA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Weak | |
| Healthy |
BABA's balance sheet is currently healthy, and its revenue is stable, but its profitability and cash flow are under pressure.
CRWS Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Strong | |
| Strong |
CRWS's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
BABA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 16x | $69.66 | -26% |
| Fair | 20x | $86.59 | -8.2% |
| Current | 21x | $94.36 | — |
| Expensive | 26x | $115 | +22% |
Historical ranges are pointers, not guarantees.
BABA's PE is 21x, but its earnings don't support one, so it isn't a reliable read right now.
CRWS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 5.2x | $2.43 | — |
| Cheap | 7.2x | $3.39 | +39% |
| Fair | 9.9x | $4.65 | +91% |
| Expensive | 12x | $5.59 | +130% |
Historical ranges are pointers, not guarantees.
CRWS has the edge over BABA in the historical PE scenario, which offers more potential upside but is not a forecast.
BABA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for BABA, with profitability improving. However, they disagree widely on these estimates.
CRWS Forward outlook
There aren't enough analyst estimates for CRWS to show an outlook.
BABA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $4.42 | -52% |
| Q1 2026 | $6.57 | -18% |
| Q4 2025 | $5.79 | -22% |
| Q3 2025 | $7.85 | +49% |
| Q2 2025 | $9.27 | +116% |
| Q1 2025 | $8.06 | +71% |
| Q4 2024 | $7.47 | +24% |
| Q3 2024 | $5.26 | -35% |
BABA has the edge over CRWS on earnings, with more consistent year-over-year improvement.
CRWS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $0.47 | +$1.41 |
| Q2 2026 | $0.46 | +$1.43 |
| Q1 2026 | $0.17 | +$1.07 |
| Q4 2025 | -$0.89 | -487% |
| Q3 2025 | -$0.94 | -403% |
| Q2 2025 | -$0.97 | -337% |
| Q1 2025 | -$0.90 | -288% |
| Q4 2024 | $0.23 | -52% |
CRWS has returned to profit: it earned $0.47 per share over the past year, after losing money the year before.
BABA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $40.2B | +8.3% |
| Q1 2026 | $36.5B | +2.9% |
| Q4 2025 | $42.7B | +1.7% |
| Q3 2025 | $37.2B | +4.8% |
| Q2 2025 | $37.2B | +1.8% |
| Q1 2025 | $35.5B | +6.6% |
| Q4 2024 | $42B | +7.6% |
| Q3 2024 | $35.5B | +5.2% |
BABA has the edge over CRWS on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 7.2% | -6.9 points |
| Q1 2026 | -0.3% | -12 points |
| Q4 2025 | 7.1% | -7.6 points |
| Q3 2025 | 2.2% | -13 points |
| Q2 2025 | 14% | -0.7 points |
| Q1 2025 | 12% | +5.4 points |
| Q4 2024 | 15% | +6.1 points |
| Q3 2024 | 15% | 0 points |
BABA's operating margin was 7.2% last quarter, down 6.9 points from the same quarter a year ago.
CRWS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $19M | -20% |
| Q2 2026 | $16.8M | +8.3% |
| Q1 2026 | $22.4M | -3.7% |
| Q4 2025 | $20.7M | -11% |
| Q3 2025 | $23.7M | -3.1% |
| Q2 2025 | $15.5M | -4.5% |
| Q1 2025 | $23.2M | +2.9% |
| Q4 2024 | $23.4M | -1.9% |
CRWS's revenue has slid since its 2022 peak: $19M last quarter, down 20% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 8.2% | +0.4 points |
| Q2 2026 | 17% | +24 points |
| Q1 2026 | 2.4% | +63 points |
| Q4 2025 | -0.5% | -7.8 points |
| Q3 2025 | 7.9% | +1.7 points |
| Q2 2025 | -7.8% | -5.9 points |
| Q1 2025 | -61% | -67 points |
| Q4 2024 | 7.3% | -2.5 points |
CRWS has the edge over BABA on profitability, with a higher operating margin.
BABA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$6.7B | -$4.1B |
| Q1 2026 | -$2.7B | +$1.5B |
| Q4 2025 | $1B | -90% |
| Q3 2025 | -$3.2B | -254% |
| Q2 2025 | -$2.7B | -182% |
| Q1 2025 | -$4.2B | -12231% |
| Q4 2024 | $10.4B | -4.8% |
| Q3 2024 | $2.1B | -62% |
BABA's free cash flow has turned negative after years in the green: −$11.6B over the past year.
CRWS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $5.4M | +$6.4M |
| Q2 2026 | $5.4M | +3.7% |
| Q1 2026 | $926K | -65% |
| Q4 2025 | $2.3M | +$2.6M |
| Q3 2025 | -$1M | +$155K |
| Q2 2025 | $5.2M | -33% |
| Q1 2025 | $2.6M | -8.5% |
| Q4 2024 | -$220K | +$451K |
CRWS has the edge over BABA on cash generation, producing positive trailing cash flow while its opponent burns cash.
BABA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.5% | +11.1M shares |
| 1 year | +0.9% | +21.4M shares |
| 3 years | -6.2% | -161M shares |
| 5 years | -12% | -339M shares |
| Available history | -8.4% | -221M shares |
BABA has the edge over CRWS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | $269.8M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
BABA spent $270M buying back its own shares over the past year, after none the year before.
CRWS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.5% | +55K shares |
| 1 year | +1.7% | +181K shares |
| 3 years | +6% | +614K shares |
| 5 years | +7.1% | +721K shares |
| Available history | +6.3% | +638K shares |
CRWS has 11M diluted shares, up 1.7% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | $18,000 |
| Q4 2022 | — |
| Q3 2022 | $27,000 |
| Q2 2022 | $162,000 |
BABA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.8x | Very low |
| Q2 2025 | 0.2x | Very low |
| Q1 2025 | 0.3x | Very low |
| Q4 2024 | 0.1x | Very low |
| Q3 2024 | -0.2x | Net Cash |
BABA has the edge over CRWS on leverage, with a lower net debt burden relative to earnings.
CRWS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.8x | Very low |
| Q2 2026 | 1.4x | Healthy |
| Q1 2026 | 5.3x | High |
| Q4 2024 | 3.5x | Elevated |
| Q3 2024 | 3.0x | Elevated |
| Q2 2024 | 0.1x | Very low |
| Q1 2024 | 0.9x | Very low |
| Q4 2023 | 1.2x | Healthy |
CRWS's net debt is less than a year of its operating earnings (EBITDA), down from 3.0 years a year ago.
BABA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.0 | Neutral |
| Stochastic | 12.7 | Oversold |
BABA's weekly RSI is 38 (neutral) and its Stochastic is 13 (oversold).
CRWS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.8 | Neutral |
| Stochastic | 18.4 | Oversold |
CRWS's weekly RSI is 34 (neutral) and its Stochastic is 18 (oversold).
BABA PE vs Consumer Cyclical Sector
| Metric | BABA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 18x | 19% above |
| PE % | 60 | 47 | 13 pts above |
BABA is trading at 21x earnings, a 19% premium to the Consumer Cyclical sector's median of 18x, though its earnings don't support one.
CRWS PE vs Consumer Cyclical Sector
| Metric | CRWS | Sector median | Relative |
|---|---|---|---|
| PE | 5.2x | 18x | 71% below |
| PE % | 0 | 47 | 47 pts below |
CRWS has the edge over BABA on valuation relative to its sector.
BABA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $104.7 | 9.9% below |
| 20 week MA | $111.1 | 15% below |
| 50 week MA | $128.0 | 26% below |
| 100 week MA | $127.7 | 26% below |
| 200 week MA | $106.4 | 11% below |
BABA is in a downtrend: it's below all five of its weekly moving averages, and 11% below its 200-week average.
CRWS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.44 | 0.4% below |
| 20 week MA | $2.70 | 10% below |
| 50 week MA | $2.76 | 12% below |
| 100 week MA | $3.05 | 20% below |
| 200 week MA | $4.06 | 40% below |
CRWS is in a downtrend: it's below all five of its weekly moving averages, and 40% below its 200-week average.
BABA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $215.5 | $222.0 | +3% |
| 2021 | $222.0 | $118.7 | -47% |
| 2022 | $118.7 | $85.7 | -28% |
| 2023 | $85.7 | $77.5 | -9.5% |
| 2024 | $77.5 | $85.1 | +9.7% |
| 2025 | $85.1 | $152.2 | +79% |
| 2026 YTD | $152.2 | $94.4 | -38% |
BABA has finished lower in three of the last six years. It's down 38% so far in 2026.
CRWS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $6.10 | $7.15 | +17% |
| 2021 | $7.15 | $7.04 | -1.5% |
| 2022 | $7.04 | $5.30 | -25% |
| 2023 | $5.30 | $4.96 | -6.4% |
| 2024 | $4.96 | $4.51 | -9.1% |
| 2025 | $4.51 | $2.67 | -41% |
| 2026 YTD | $2.67 | $2.43 | -9% |
CRWS has the edge over BABA on returns for 2026, with the stronger performance.